Office for National Statistics. Sexual offences prevalence and victim characteristics, England and Wales, 2023. [Dataset].
2.
Office for National Statistics. Sexual offences in England and Wales overview: year ending March 2020, 2021. [Statistical Bulletin].
3.
van RooijenMSSchim van der LoeffMFvan KempenL, et al.Sexually transmitted infection positivity rate and treatment uptake among female and male sexual assault victims attending the Amsterdam STI clinic between 2005 and 2016. Sex Transm Dis2018; 45(8): 534–541.
4.
KerrECotteeCChowdhuryR, et al.The Haven: a pilot referral centre in London for cases of serious sexual assault. BJOG2003; 110: 267–271.
5.
SkjælaaenKNesvoldHBrekkeM, et al.Sexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway. BMJ Open2022; 12: e064934.
6.
RossiLHGonthierHLe GalloA, et al.Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among sexual assault victims referred to three French clinical forensic units. Forensic Sci Int2024; 360: 112070.
7.
LambaHMurphySM. Sexual assault and sexually transmitted infections: an updated review. Int J STD AIDS2000; 11(8): 487–491.
8.
KaneDHolmesAEoganM. Post-exposure prophylaxis, STI testing and factors associated with follow-up attendance: a review of 4159 cases of acute post-sexual assault medical care. SexTransm Inf2023; 100: 39–44.
9.
British Association for Sexual Health and HIV (BASHH). National guidelines for the management of individuals disclosing sexual violence in sexual health services, 2022.
10.
US Centers for Disease Control and Prevention (CDC). Sexual assault and abuse and STIs – adolescents and adults. STI Treatment guidelines2021.
11.
World Health Organization (WHO). Guidelines for medico-legal care for victims of sexual violence. 2021.
12.
JinaRJewkesRMunjanjaSP, et al.Report of the FIGO working Group on sexual violence/HIV: guidelines for the management of female survivors of sexual assault. Int J Gynaecol Obstet2010; 109: 85–92.
13.
SaundersJDeeringJDewsnapC, et al.British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025. Int J STD AIDS2025; 0(0): 9564624251352053.
14.
AckermanDRSugarNFFineDN, et al.Sexual assault victims: factors associated with follow-up care. AJOG2006; 194(6): 1653–1659.
15.
HerbertCGramsGBerkowitzJ. Sexual assault tracking study: who gets lost to follow-up?CMAJ (Can Med Assoc J)1992; 147: 1177–1184.
16.
RambowBAdkinsonCFrostTH, et al.Female sexual assault: medical and legal implications. Ann Emerg Med1993; 21(6): 727–731.
17.
HolmesMMResnickHSFramptonD. Follow-up of sexual assault victims. Am J Obstet Gynecol1998; 179(2): 336–342.
18.
MayerKHMolinaJMThompsonMA, et al.Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet2020; 396(10246): 239–254.
19.
StewartJOwareKDonnellD, et al.Doxycycline prophylaxis to prevent sexually transmitted infections in women. N Engl J Med2023; 389(25): 2331–2340.
20.
KwachBKwenaZVioletteLR, et al.Understanding barriers and facilitators to doxycycline post-exposure prophylaxis adherence among young women in western kenya: a qualitative study. BMC Infect Dis. 2025; 25: 855.
21.
HaalandREFountainJEdwardsTE, et al.Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infections. EBioMedicine2024; 101: 105037.
22.
GibbAMMcManusTForsterGE. Should we offer antibiotic prophylaxis post sexual assault?Int J STD AIDS2003; 14(2): 99–102.
